Publications by authors named "Durk Dijkstra"

Claim this Profile
T
The pharmacokinetics and pharmacological effect of (S)-5-OH-DPAT following controlled delivery with transdermal iontophoresis.
Oliver W Ackaert, Jeroen De Graan, Shanna Shi, Rob Vreeken, Oscar E Della Pasqua, Durk Dijkstra

J Pharm Sci· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdermal iontophoretic delivery of a novel series of dopamine agonists in vitro: physicochemical considerations.
Oliver W Ackaert, Jeroen De Graan, Romano Capancioni, Durk Dijkstra, Meindert Danhof

J Pharm Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic studies of the transdermal iontophoretic delivery of 5-OH-DPAT in vitro.
Oliver W Ackaert, Jeroen Van Smeden, Jeroen De Graan, Durk Dijkstra, Meindert Danhof

J Pharm Sci· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel synthesis and pharmacological evaluation of a potential dopamine D1/D2 agonist: 1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol.
Danyang Liu, Durk Dijkstra, Jan B de Vries, Håkan V Wikström

Bioorg Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics analysis of transdermal iontophoresis of 5-OH-DPAT in rats: in vitro-in vivo correlation.
Akhmad Kharis Nugroho, Stefan G Romeijn, Raphaël Zwier, Jan B de Vries, Durk Dijkstra

J Pharm Sci· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected].
Danyang Liu, Håkan V Wikström, Durk Dijkstra, Jan B de Vries, Bastiaan J Venhuis

J Med Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
Erik F J de Vries, Rudie Kortekaas, Aren van Waarde, Durk Dijkstra, Philip H Elsinga

J Nucl Med· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
Akhmad Kharis Nugroho, Li Li, Durk Dijkstra, Håkan Wikström, Meindert Danhof

J Control Release· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta.
Rudie Kortekaas, R Paul Maguire, Thomas I Cremers, Durk Dijkstra, Aren van Waarde

J Cereb Blood Flow Metab· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity.
Bastiaan J Venhuis, Durk Dijkstra, David Wustrow, Len T Meltzer, Lawrence D Wise

J Med Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally active analogues of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one: synthesis and pharmacological activity.
Bastiaan J Venhuis, Durk Dijkstra, David J Wustrow, Leonard T Meltzer, Lawrence D Wise

J Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further characterization of structural requirements for ligands at the dopamine D(2) and D(3) receptor: exploring the thiophene moiety.
Durk Dijkstra, Nienke Rodenhuis, Erik S Vermeulen, Thomas A Pugsley, Lawrence D Wise

J Med Chem· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's disease.
Bastiaan J Venhuis, Nienke Rodenhuis, Håkan V Wikström, David Wustrow, Leonard T Meltzer, Durk Dijkstra

J Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis